Viewing Study NCT05100134


Ignite Creation Date: 2025-12-25 @ 2:18 AM
Ignite Modification Date: 2026-01-09 @ 10:41 PM
Study NCT ID: NCT05100134
Status: AVAILABLE
Last Update Posted: 2025-12-09
First Post: 2021-10-19
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Managed Access Programs for LDK378, Ceritinib
Sponsor: Novartis Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module